Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4
- 1 January 2005
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 44 (7), 723-727
- https://doi.org/10.1080/02841860500218561
Abstract
Small cell lung cancer (SCLC) comprises 15-20% of all lung cancer. Despite high initial response to chemotherapy chemoresistance at relapse leads to a less than 5% five-year survival rate. Adjuvant treatment with monoclonal antibodies (Mabs) against SCLC antigens may offer a therapeutic option. Mab 17-1A directed against the epithelial-cell adhesion molecule (Ep-CAM) has been extensively tested for therapy in patients with colorectal carcinoma. Expression of Ep-CAM in SCLC has been earlier described. However, reactivity of Mab 17-1A and another Ep-CAM-binding Mab BerEP4 has not yet been described for SCLC. Using immunohistology first with BerEP4 and confirmatory with 17-1A a homogenous and strong expression of Ep-CAM was seen in all SCLC specimens tested (n = 10). For comparison, heterogenous expression was seen in the non-SCLC tumors tested (n = 15). These findings strongly suggest that Mab 17-1A can be useful for adjuvant immunotherapy in patients with SCLC. For detection of Ep-CAM in tumor tissue in patients that might be considered for immunotherapy with Mab 17-1A, Mab BerEP4 appears to be preferred.Keywords
This publication has 20 references indexed in Scilit:
- Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised studyThe Lancet, 2002
- The expression of Ep-CAM (17-1 A)in squamous cell cancers of the lungHuman Pathology, 2000
- Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cellsCytotherapy, 2000
- The biology of the 17–1A antigen (Ep-CAM)Journal of Molecular Medicine, 1999
- Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME‐1 expressionHistopathology, 1997
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysisInternational Journal of Cancer, 1994
- SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2International Journal of Cancer, 1994
- A phase II trial of murine monoclonal antibody 17-1A and interferon-γ: Clinical and immunological dataCancer Immunology, Immunotherapy, 1990
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proceedings of the National Academy of Sciences of the United States of America, 1979